Jasper Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | -94.4% | +1,695.2% | +247.5% | -15.4% | +23.9% | -23.1% | |
| – | +20,066.7% | -13.4% | +290.4% | +27.4% | +27.0% | +1.4% | |
| – | +440.4% | -90.7% | -1,712.0% | – | – | – | |
| – | -6.9% | -201.6% | – | – | -96.6% | -2,945.7% | |
| – | +0.0% | +0.0% | -76.3% | -53.6% | +106.7% | -98.7% | |
| – | – | -1,324.1% | -76.3% | -53.6% | +99.3% | – | |
| – | – | – | -99.5% | -3,528.6% | – | -32.5% | |
| – | – | – | – | – | – | – | |
| – | -61.3% | +794.6% | -99.9% | +183,483.6% | -52.6% | -28.6% | |
| – | -125.7% | – | -171.6% | – | -131.4% | – | |
| – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.